Longitudinal Assessment of the Impact of Prevalent Diabetes on Hospital Admissions and Mortality in the General Population: a Prospective Population-based Study with 19 Years of Follow-up

Overview

Journal BMC Public Health

Publisher Biomed Central

Specialty Public Health

Date 2024 Oct 25

PMID 39448967

Authors

Madeleine Johansson

Anna Akesson

Peter M Nilsson

Olle Melander

Affiliations

Soon will be listed here.

Abstract

Background: Hospitalization indicates the presence of severe disease and constitutes a leading cost in health care. We aimed to prospectively assess if prevalent diabetes mellitus contributes to excess all-cause and cause-specific hospital admissions and mortality at the population level.

Methods: We used a Swedish prospective population-based cohort, including 25,642 individuals of whom 4.2% had prevalent diabetes at baseline (mean age 61.2 ± 6.8 years, age range 44.8-73.4 years). We compared the number of hospitalizations and mortality classified according to the main chapters of the 10th revision of the International Classification of Diseases (ICD-10) during follow-up using nationwide inpatient registries, comparing individuals with and without prevalent diabetes, using multivariate adjusted negative binomial regression (incidence rate ratio, IRR) and Cox regression, respectively.

Results: During a median follow-up of 19 years, 18,904 subjects were hospitalized at least once [median 3 (IQR 2-6)] and 6767 (26.4%) individuals died. Overall, subjects with diabetes were hospitalized (IRR 1.83, p < 0.001) more often, and had a higher incidence rate of hospital admissions due to endocrine diseases (IRR 14.6, p < 0.001), dermatological diseases (IRR 3.7, p < 0.001), injuries and poisoning (IRR 2.7, p < 0.001), infectious diseases (IRR 2.5, p < 0.001), psychiatric diseases (IRR 2.0, p < 0.001), but also cardiovascular, hematological, genitourinary, neurologic and respiratory diseases compared with non-diabetic individuals. No difference was observed for hospital admissions due to cancer or musculoskeletal disorders. All-cause mortality was higher (HR 1.77, p < 0.001) in individuals with diabetes, with disease-specific mortality being significant only for cardiovascular and endocrine disease-related death.

Conclusions: At the population level, prevalent diabetes increased the hospitalization burden longitudinally due to diseases of most of the ICD-10 main chapters, except for cancer and musculoskeletal disorders. These novel findings challenge the current view on the spectrum of prevalent diabetes-related conditions and may have implications for screening and treatment strategies in diabetes.

Permission Of Graphical Illustrations: Source: Pixabay.com. No permission or acknowledgement is required.

References

Kim S . Burden of hospitalizations primarily due to uncontrolled diabetes: implications of inadequate primary health care in the United States. Diabetes Care. 2007; 30(5):1281-2. DOI: 10.2337/dc06-2070. View

Raghavan S, Vassy J, Ho Y, Song R, Gagnon D, Cho K . Diabetes Mellitus-Related All-Cause and Cardiovascular Mortality in a National Cohort of Adults. J Am Heart Assoc. 2019; 8(4):e011295. PMC: 6405678. DOI: 10.1161/JAHA.118.011295. View

David P, Singh S, Ankar R . A Comprehensive Overview of Skin Complications in Diabetes and Their Prevention. Cureus. 2023; 15(5):e38961. PMC: 10259731. DOI: 10.7759/cureus.38961. View

Gudbjornsdottir S, Cederholm J, Nilsson P, Eliasson B . The National Diabetes Register in Sweden: an implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care. Diabetes Care. 2003; 26(4):1270-6. DOI: 10.2337/diacare.26.4.1270. View

Colagiuri S, Best J . Lipid-lowering therapy in people with type 2 diabetes. Curr Opin Lipidol. 2002; 13(6):617-23. DOI: 10.1097/00041433-200212000-00004. View

Gaede P, Vedel P, Larsen N, Jensen G, Parving H, Pedersen O . Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003; 348(5):383-93. DOI: 10.1056/NEJMoa021778. View

Wu F, Jing Y, Tang X, Li D, Gong L, Zhao H . Anemia: an independent risk factor of diabetic peripheral neuropathy in type 2 diabetic patients. Acta Diabetol. 2017; 54(10):925-931. DOI: 10.1007/s00592-017-1025-7. View

Brooke H, Talback M, Hornblad J, Johansson L, Ludvigsson J, Druid H . The Swedish cause of death register. Eur J Epidemiol. 2017; 32(9):765-773. PMC: 5662659. DOI: 10.1007/s10654-017-0316-1. View

Boyle J, Honeycutt A, Narayan K, Hoerger T, Geiss L, Chen H . Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care. 2001; 24(11):1936-40. DOI: 10.2337/diacare.24.11.1936. View

10.

Smith J, Platonov P, Hedblad B, Engstrom G, Melander O . Atrial fibrillation in the Malmö Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol. 2009; 25(2):95-102. DOI: 10.1007/s10654-009-9404-1. View

11.

Manjer J, Carlsson S, Elmstahl S, Gullberg B, Janzon L, Lindstrom M . The Malmö Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev. 2002; 10(6):489-99. DOI: 10.1097/00008469-200112000-00003. View

12.

Ludvigsson J, Almqvist C, Edstedt Bonamy A, Ljung R, Michaelsson K, Neovius M . Registers of the Swedish total population and their use in medical research. Eur J Epidemiol. 2016; 31(2):125-36. DOI: 10.1007/s10654-016-0117-y. View

13.

Kim H, Helmer D, Zhao Z, Boockvar K . Potentially preventable hospitalizations among older adults with diabetes. Am J Manag Care. 2011; 17(11):e419-26. View

14.

Knowler W, Barrett-Connor E, Fowler S, Hamman R, Lachin J, Walker E . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346(6):393-403. PMC: 1370926. DOI: 10.1056/NEJMoa012512. View

15.

Wettermark B, Hammar N, Fored C, MichaelFored C, Leimanis A, Olausson P . The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2006; 16(7):726-35. DOI: 10.1002/pds.1294. View

16.

Lindholm E, Agardh E, Tuomi T, Groop L, Agardh C . Classifying diabetes according to the new WHO clinical stages. Eur J Epidemiol. 2002; 17(11):983-9. DOI: 10.1023/a:1020036805655. View

17.

Rubens M, Ramamoorthy V, Saxena A, McGranaghan P, McCormack-Granja E . Recent Trends in Diabetes-Associated Hospitalizations in the United States. J Clin Med. 2022; 11(22). PMC: 9698503. DOI: 10.3390/jcm11226636. View

18.

Jaul E, Barron J . Age-Related Diseases and Clinical and Public Health Implications for the 85 Years Old and Over Population. Front Public Health. 2018; 5:335. PMC: 5732407. DOI: 10.3389/fpubh.2017.00335. View

19.

Lee M, Lee S, Sohn S, Ahn J, Han K, Lee J . Type 2 Diabetes and Its Association With Psychiatric Disorders in Young Adults in South Korea. JAMA Netw Open. 2023; 6(6):e2319132. PMC: 10314316. DOI: 10.1001/jamanetworkopen.2023.19132. View

20.

Cederholm J, Eeg-Olofsson K, Eliasson B, Zethelius B, Nilsson P, Gudbjornsdottir S . Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register. Diabetes Care. 2008; 31(10):2038-43. PMC: 2551651. DOI: 10.2337/dc08-0662. View